Chest pain med is effective for refractory angina, but adherence problematic
Monday, April 4, 2011 - 10:03
in Health & Medicine
Ranolazine (Ranexa, Gilead) is an effective anti-anginal therapy in patients with refractory angina; however, at one year only 59 percent of patients remained on the drug, according to a scientific poster that will be presented at the American College of Cardiology (ACC) Scientific Sessions in New Orleans, April 1-3.